These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 19260522
1. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma. Mabuchi N, Niwa Y, Hirooka Y, Ohmiya N, Itoh A, Maeda O, Ando T, Goto H. Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522 [Abstract] [Full Text] [Related]
2. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. Kawachi H, Takizawa T, Eishi Y, Shimizu S, Kumagai J, Funata N, Koike M. J Pathol; 2003 Apr; 199(4):436-46. PubMed ID: 12635134 [Abstract] [Full Text] [Related]
3. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835 [Abstract] [Full Text] [Related]
7. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness. Han HS, Lee SY, Lee KY, Hong SN, Kim JH, Sung IK, Park HS, Jin CJ, Min YI. J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827 [Abstract] [Full Text] [Related]
8. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Sasaki I, Yao T, Nawata H, Tsuneyoshi M. Cancer; 1999 Apr 15; 85(8):1719-29. PubMed ID: 10223565 [Abstract] [Full Text] [Related]
9. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma. Takano K, Hasegawa G, Jiang S, Kurosaki I, Hatakeyama K, Iwanari H, Tanaka T, Hamakubo T, Kodama T, Naito M. Pathol Int; 2009 Jul 15; 59(7):462-70. PubMed ID: 19563409 [Abstract] [Full Text] [Related]
10. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype. Watari J, Saitoh Y, Fujiya M, Shibata N, Tanabe H, Inaba Y, Okamoto K, Maemoto A, Ohta T, Yasuda A, Ayabe T, Ashida T, Yokota K, Obara T, Kohgo Y. J Gastroenterol; 2004 Jul 15; 39(2):104-12. PubMed ID: 15069616 [Abstract] [Full Text] [Related]
11. The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer. Nakamura Y, Yanai H, Kitoh T, Matsubara Y, Hirano A, Okamoto T, Yoshida T, Nishikawa J, Okita K. Hepatogastroenterology; 2008 Jul 15; 55(81):41-5. PubMed ID: 18507075 [Abstract] [Full Text] [Related]
12. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Hum Pathol; 2003 Jan 15; 34(1):32-40. PubMed ID: 12605364 [Abstract] [Full Text] [Related]
13. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance]. Gao X, Sun Y, Huang L, Chen XY, Zhang KL, Kong QY, Liu J, Li H. Ai Zheng; 2005 Mar 15; 24(3):311-6. PubMed ID: 15757532 [Abstract] [Full Text] [Related]
15. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Nakamura T, Yao T, Kabashima A, Nishiyama K, Maehara Y, Tsuneyoshi M. Histopathology; 2005 Oct 15; 47(4):357-67. PubMed ID: 16178890 [Abstract] [Full Text] [Related]
16. Expression of MUC2 in gastric carcinomas and background mucosae. Lee HW, Yang DH, Kim HK, Lee BH, Choi KC, Choi YH, Park YE. J Gastroenterol Hepatol; 2007 Aug 15; 22(8):1336-43. PubMed ID: 17559374 [Abstract] [Full Text] [Related]
19. Intestinal metaplasia and gastric carcinoma. A histochemical and immunohistochemical study. Jiang YQ, Du XX, Guo SY, Ma Z. Chin Med J (Engl); 1990 Oct 15; 103(10):821-5. PubMed ID: 2125255 [Abstract] [Full Text] [Related]